April 6, 2020
MedinCell Has Launched a COVID-19 Research Initiative Based on Its Experience to Formulate Long-Acting Injectable Ivermectin
First in-vitro validation of impact of Ivermectin on Covid-19 by Australian researchers MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: MedinCell (Paris:MEDCL) Researchers at…